Ovarian expression of insulin-like peptide 3 (INSL3) and its receptor (RXFP2) during development of bovine antral follicles and corpora lutea and measurement of circulating INSL3 levels during synchronized estrous cycles

Endocrinology

Volumn 154, Issue 5, 2013, Pages 1897-1906

  Satchell, Leanne ^a   Glister, Claire ^a   Bleach, Emma C ^b   Glencross, Richard G ^a   Bicknell, Andrew B ^a   Dai, Yanzhenzi ^c   Anand Ivell, Ravinder ^c   Ivell, Richard ^c   Knight, Philip G ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b HARPER ADAMS UNIVERSITY   (United Kingdom)

^c LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); INSULIN LIKE PEPTIDE 3; LUTEINIZING HORMONE; MESSENGER RNA; PEPTIDE; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BLOOD; BLOOD LEVEL; CATTLE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CORPUS LUTEUM; DOWN REGULATION; ESTRUS; FEMALE; GENE EXPRESSION; GRANULOSA CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; LUTEINIZATION; LUTEOLYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY FOLLICLE; OVARY FOLLICLE MATURATION; OVULATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGESTERONE RELEASE; PROTEIN EXPRESSION; STEROIDOGENESIS;

ANIMALS; BLOOD CHEMICAL ANALYSIS; CATTLE; CELLS, CULTURED; CLOPROSTENOL; CORPUS LUTEUM; ESTROUS CYCLE; ESTRUS SYNCHRONIZATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INSULIN; LUTEOLYTIC AGENTS; OVARIAN FOLLICLE; OVARY; PROTEINS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84876766017     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2232     Document Type: Article

References (58)

1. Adham IM, Burkhardt E, Benahmed M, Engel W. Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem. 1993;268:26668-26672.
2. Ivell R, Anand-Ivell R. Biology of insulin-like factor 3 in human reproduction. Hum Reprod Update. 2009;15:463-476.
3. Ivell R, Anand-Ivell R. Biological role and clinical significance of insulin-like peptide 3. Curr Opin Endocrinol Diabetes Obes. 2011; 18:210-216.
4. Ivell R, Hartung S. The molecular basis of cryptorchidism. MolHum Reprod. 2003;9:175-181.
5. Nef S, Parada LF. Cryptorchidism in mice mutant for Insl3. Nat Genet. 1999;22:295-299.
6. Zimmermann S, Steding G, Emmen JM, et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol. 1999;13:681-691.
7. Bathgate RA, Lin F, Hanson NF, et al. Relaxin-3: improved synthesis strategy and demonstration of its high-Affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry. 2006;45:1043-1053.
8. Bogatcheva NV, Truong A, Feng S, Engel W, Adham IM, Agoulnik AI.GREAT/LGR8is the only receptor for insulin-like 3 peptide. Mol Endocrinol. 2003;17:2639-2646.
9. Gorlov IP,KamatA, BogatchevaNV,et al. Mutations of theGREAT gene cause cryptorchidism. Hum Mol Genet. 2002;11:2309-2318.
10. Bamberger AM, Ivell R, Balvers M, et al. Relaxin-like factor (RLF): a new specific marker for Leydig cells in the ovary. Int J Gynecol Pathol. 1999;18:163-168.
11. Bathgate R, Balvers M, Hunt N, Ivell R. Relaxin-like factor gene is highly expressed in the bovine ovary of the cycle and pregnancy: sequence and messenger ribonucleic acid analysis. Biol Reprod. 1996;55:1452-1457.
12. Hanna CB, Yao S, Patta MC, Jensen JT, Wu X. Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques. Reprod Biol Endocrinol. 2010;8:150.
13. Havelock JC, Bay K, Ivell R, Bathgate RA, Rodgers RJ, Carr BR. A novel hormone known as insulin-like factor 3 (INSL3) is expressed in the human ovary and serum levels are increased in women with polycystic ovary syndrome (PCOS). Fertil Steril. 2005;84:S4 (Abstract).
14. Irving-Rodgers HF, Bathgate RA, Ivell R, Domagalski R, Rodgers RJ. Dynamic changes in the expression of relaxin-like factor (INSL3), cholesterol side-chain cleavage cytochrome p450, and 3-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia. Biol Reprod. 2002;66:934-943.
15. TashimaLS, HieberAD,GreenwoodFC, Bryant-GreenwoodGD.The human Leydig insulin-like (hLEY I-L) gene is expressed in the corpus luteum and trophoblast. J Clin Endocrinol Metab. 1995;80:707-710.
16. Zarreh-Hoshyari-Khah MR, Einspanier A, Ivell R. Differential splicing and expression of the relaxin-like factor gene in reproductive tissues of the marmoset monkey (Callithrix jacchus). Biol Reprod. 1999;60:445-453.
17. Spanel-Borowski K, Schäfer I, Zimmermann S, Engel W, Adham IM. Increase in final stages of follicular atresia and premature decay of corporalutea in Insl3-deficient mice.MolReprodDev.2001;58:281-286.
18. Bathgate R, Moniac N, Bartlick B, Schumacher M, Fields M, Ivell R. Expression and regulation of relaxin-like factor gene transcripts in the bovine ovary: differentiation-dependent expression in theca cell cultures. Biol Reprod. 1999;61:1090-1098.
19. Bay K, Hartung S, Ivell R, et al. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J Clin Endocrinol Metab. 2005;90:3410-3418.
20. Gambineri A, Patton L,DeIasio R, Palladoro F, Pagotto U, Pasquali R. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependentovarianhyperandrogenismin the polycysticovary syndrome. J Clin Endocrinol Metab. 2007;92:2066-2073.
21. Anand-Ivell R, Hiendleder S, Vinoles C, et al.INSL3in the ruminant: a powerful indicator of gender-And genetic-specific feto-maternal dialogue. PloS One. 2011;6:e19821.
22. Glister C, Satchell L, Knight PG. Changes in expression of bone morphogenetic proteins (BMPs), their receptors and inhibin co-receptor -glycan during bovine antral follicle development: inhibin can antagonize the suppressive effect of BMPs on thecal androgen production. Reproduction. 2010;140:699-712.
23. Ireland JJ, Murphee RL, Coulson PB. Accuracy of predicting stages of bovine estrous cycle by gross appearance of the corpus luteum. J Dairy Sci. 1980;63:155-160.
24. Glister C, Richards SL, Knight PG. Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormoneinduced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecalBMPsignaling? Endocrinology. 2005;146:1883-1892.
25. Glencross RG, Abeywardene SA, Corney SJ, Morris HS. The use of oestradiol-17-Antiserum covalently coupled to sepharose to extract oestradiol-17-from biological fluids. J Chromatogr. 1981;223:193-197.
26. Glencross RG, Bleach EC,WoodSC, Knight PG. Active immunization of heifers against inhibin: effects on plasma concentrations of gonadotrophins, steroids and ovarian follicular dynamics during prostaglandin-synchronized cycles. J Reprod Fertil. 1994;100:599-605.
27. Bleach EC, Glencross RG, Feist SA, Groome NP, Knight PG. Plasma inhibin A in heifers: relationship with follicle dynamics, gonadotropins, and steroids during the estrous cycle and after treatment with bovine follicular fluid. Biol Reprod. 2001;64:743-752.
28. Glencross RG, Bleach EC, McLeod BJ, Beard AJ, Knight PG. Effect of active immunization of heifers against inhibin on plasma FSH concentrations, ovarian follicular development and ovulation rate. J Endocrinol. 1992;134:11-18.
29. Sauer MJ, Foulkes JA, Worsfold A, Morris BA. Use of progesterone 11-glucuronide-Alkaline phosphatase conjugate in a sensitive microtitre-plate enzymeimmunoassay of progesterone in milk and its application to pregnancy testing in dairy cattle. J Reprod Fertil. 1986;76:375-391.
30. Glister C, Satchell L, Bathgate R, et al. Functional link between bone morphogenetic protein and insulin-like peptide 3 signaling in modulating ovarian androgen production [published online March 25, 2013]. Proc Natl Acad Sci USA. doi:10.1073/pnas.1222216110.
31. Kayani AR, Glister C, Knight PG. Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle. Reproduction. 2009;137:67-78.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
33. Ivell R, Balvers M, Pohnke Y, et al. A Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates. Reprod Biol Endocrinol. 2003;1:114.
34. Ireland JJ, Mihm M, Austin E, Diskin MG, Roche JF. Historical perspective of turnover of dominant follicles during the bovine estrous cycle: key concepts, studies, advancements, and terms. J Dairy Sci. 2000;83:1648-1658.
35. Bao B, Garverick HA. Expression of steroidogenic enzyme and gonadotropin receptor genes in bovine follicles during ovarian follicular waves: a review. J Anim Sci. 1998;76:1903-1921.
36. Webb R, Nicholas B, Gong JG, et al. Mechanisms regulating follicular development and selection of the dominant follicle. Reprod Suppl. 2003;61:71-90.
37. Fortune JE, Rivera GM, Evans AC, Turzillo AM. Differentiation of dominant versus subordinate follicles in cattle. Biol Reprod. 2001; 65:648-654.
38. Mihm M, Evans AC. Mechanisms for dominant follicle selection in monovulatory species: a comparison of morphological, endocrine and intraovarian events in cows, mares and women. Reprod Domest Anim. 2008;43(suppl 2):48 -56.
39. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod. 1994;9:188-191.
40. Young JM, McNeilly AS. Theca: the forgotten cell of the ovarian follicle. Reproduction. 2010;140:489-504.
41. Magoffin DA, Kurtz KM, Erickson GF. Insulin-like growth factor-I selectively stimulates cholesterol side-chain cleavage expression in ovarian theca-interstitial cells. Mol Endocrinol. 1990;4:489-496.
42. Spicer LJ, Stewart RE. Interaction among bovine somatotropin, insulin, and gonadotropins on steroid production by bovine granulosa and thecal cells. J Dairy Sci. 1996;79:813-821.
43. Hillier SG. Regulatory functions for inhibin and activin in human ovaries. J Endocrinol. 1991;131:171-175.
44. Hsueh AJ, Dahl KD, Vaughan J, et al. Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci USA. 1987;84:5082-5086.
45. Wrathall JH, Knight PG. Effects of inhibin-related peptides and oestradiol on androstenedione and progesterone secretion by bovine theca cells in vitro. J Endocrinol. 1995;145:491-500.
46. Roberts AJ, Skinner MK. Estrogen regulation of thecal cell steroidogenesis and differentiation: thecal cell-granulosa cell interactions. Endocrinology. 1990;127:2918-2929.
47. Magoffin DA, Gancedo B, Erickson GF. Transforming growth factor-promotes differentiation of ovarian thecal-interstitial cells but inhibits androgen production. Endocrinology. 1989;125:1951-1958.
48. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ. Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J Clin Endocrinol Metab. 1991;72:1206-1211.
49. Dooley CA, Attia GR, Rainey WE, Moore DR, Carr BR. Bone morphogenetic protein inhibits ovarian androgen production. J Clin Endocrinol Metab. 2000;85:3331-3337.
50. Andreani CL, Payne DW, Packman JN, Resnick CE, Hurwitz A, Adashi EY. Cytokine-mediated regulation of ovarian function. Tumor necrosis factor-inhibits gonadotropin-supported ovarian androgen biosynthesis. J Biol Chem. 1991;266:6761-6766.
51. Weitsman SR, Magoffin DA. Transforming growth factor-α inhibition of luteinizing hormone-stimulated androgen production by ovarian theca-interstitial cells: mechanism of action. Endocrine. 1995;3:415-420.
52. Pathirana IN, Kawate N, Büllesbach EE, et al. Insulin-like peptide 3 stimulates testosterone secretion in mouse Leydig cells via cAMP pathway. Regul Pept. 2012;178:102-106.
53. Komar CM, Berndtson AK, Evans AC, Fortune JE. Decline in circulating estradiol during the periovulatory period is correlated with decreases in estradiol and androgen, and in messenger RNA for p450 aromatase and p450 17-hydroxylase, in bovine preovulatory follicles. Biol Reprod. 2001;64:1797-1805.
54. Voss AK, Fortune JE. Levels of messenger ribonucleic acid for cholesterol side-chain cleavage cytochrome P-450 and 3-hydroxysteroid dehydrogenase in bovine preovulatory follicles decrease after the luteinizing hormone surge. Endocrinology. 1993;132:888-894.
55. Gambineri A, Patton L, Prontera O, et al. Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome. J Endocrinol Invest. 2011;34:685-691.
56. Evans AC, Komar CM, Wandji SA, Fortune JE. Changes in androgen secretion and luteinizing hormone pulse amplitude are associated with the recruitment and growth of ovarian follicles during the luteal phase of the bovine estrous cycle. Biol Reprod. 1997;57:394-401.
57. Peterson AJ, Fairclough RJ, Smith JF. Radioimmunoassay of androstenedione and testosterone in cow plasma at the time of luteolysis and oestrus. J Reprod Fertil. 1978;52:127-129.
58. Gilling-Smith C, Willis DS, Franks S. Oestradiol feedback stimulation of androgen biosynthesis by human theca cells. Hum Reprod. 1997;12:1621-1628.